
While the P4 trial represents a landmark study on the use of CCTA guidance for percutaneous coronary intervention (PCI), there are pertinent caveats that warrant closer inspection.
In the spirit of the season, DI SCAN is taking a break. Coverage will resume Jan. 2.
In the spirit of the season, DI SCAN is taking a break. Coverage will resume Jan. 2.






